News

Exciting Updates from VolitionRx's Upcoming Conference Call

Exciting Updates from VolitionRx's Upcoming Conference Call

VolitionRx Limited Hosting Earnings Conference Call

VolitionRx Limited (NYSE AMERICAN: VNRX) is all set to engage with investors and stakeholders in an upcoming conference call. This event promises to provide crucial insights into the company's financial health and recent business developments.

Details of the Conference Call

On the horizon, the conference call is scheduled for a Friday morning at 8:30 a.m. U.S. Eastern Time. It aims to cover financial and operational results for the current quarter alongside an insightful business update. Participants will find ways to join through various methods outlined below.

Conference Call Event: VolitionRx Limited Second Quarter Earnings and Business Update Conference Call
Date: Friday, August 15, 2025
Time: 8:30 a.m. U.S. Eastern Time / 2:30 p.m. Central European Time

How to Join the Call

Individuals located in the U.S. and Canada can participate by dialing a toll-free number, while those in the U.K. and other international locations have separate dialing options to ensure inclusion. The provided conference ID will assist attendees in connecting swiftly.

U.S. & Canada Dial-in: 1-877-407-9716 (toll-free)
U.K. Dial-in: 0 800 756 3429 (toll-free)
Toll/International: 1-201-493-6779
Conference ID: 13755349

Who Will Be Speaking?

Expect to hear from prominent figures including Louise Batchelor, Group Chief Marketing & Communications Officer, joined by Cameron Reynolds, President, and Group CEO. Other executives, including the Group CFO and Chief Medical Officer, will share their insights during the call, highlighting significant developments from the quarter and future goals.

Accessing the Live Webcast and Replay

For those unable to attend the live call, a webcast link will provide audio access to the session. Moreover, a replay will be accessible for a limited period after the event, allowing even more stakeholders to benefit from the information shared and insights offered.

Replay Dial-in Numbers:
U.S. and Canada: 1-844-512-2921 (toll-free)
International: 1-412-317-6671 (toll)
Please use replay pin number 13755349.

About VolitionRx Limited

VolitionRx is recognized globally for its dedication to advancing the field of epigenetics, focusing on innovative diagnostics to enhance healthcare outcomes for both humans and animals. Their work centers around developing intuitive and cost-effective blood tests aimed at detecting various diseases, including certain cancers, thereby enabling timely medical intervention and monitoring.

The company’s research and development efforts primarily occur in Belgium, supplemented by innovation labs and offices in other locations to foster collaborative progress and breakthroughs in diagnostics.

VolitionRx is committed to ensuring earlier detection and monitoring of diseases, ultimately improving patient quality of life.

Media Inquiries

For any media inquiries, contact Louise Batchelor via email or phone for comprehensive assistance and information.

Investor Relations

Engage with Jeremy Feffer at LifeSci Advisors for investor inquiries regarding the company's performance or future directions.

Frequently Asked Questions

When is the earnings call scheduled?

The earnings call is set for Friday, August 15, 2025, at 8:30 a.m. U.S. Eastern Time.

Who are the key speakers at the conference call?

The call will feature executives including Louise Batchelor, Cameron Reynolds, and other key leaders from VolitionRx.

How can participants join the conference call?

Participants can join by dialing the provided numbers or accessing the live audio webcast via the instructions shared in the release.

What topics will be discussed during the call?

The conference will cover financial results, significant company developments, and upcoming milestones.

Where is VolitionRx focused geographically?

VolitionRx conducts research primarily in Belgium, with additional operations in the U.S. and other locations to drive innovation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 3

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 4

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Diaper Affordability: A Hidden Crisis, Taxpayer Burden

Updated Category News Views 6

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading
OneAscent Welcomes Monica Stoudemire as New CCO

Updated Category News Views 3

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 4

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 4

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 3

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading